ARTICLE | Company News
Amgen updates Aranesp progress
June 29, 2001 7:00 AM UTC
AMGN said the company will not receive FDA approval for Aranesp modified erythropoietin in the first half of this year as it had expected, but said that discussions with the FDA are progressing. AMGN ...